RxDoctor Payments Data

Kathleen Sawada, MD

Dermatology · Golden, CONPI 1053303115

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,243 of the $9,943 with a category attached, or 72.8%. It is spread thinly across 33 manufacturers, the largest accounting for just 17.1%. Reporting peaked in 2022 at $2,752 and has fallen 96.2% since, to $105 in 2025.

$9,943in general payments, 2019–2025

Across 218 payments — averaging $45.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EPI Health, LLC$2K
  • Biofrontera Inc.$2K
  • Merz North America, Inc.$1K
  • Galderma Laboratories, L.p.$923
  • AbbVie$662
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$634
  • plus $3K from 27 others
$49,819in research payments, 2019–2025

Across 12 payments — averaging $4151.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bausch Health US, LLC$50K

What the payments were for

  • Consulting fees$1,50015%
  • Speaking & faculty fees$1,20012%
  • Food & beverage$7,24373%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,943 in reported general payments places this provider in the 85th percentile of 280 dermatology providers in Colorado.

See all dermatology providers in Colorado

Medicare billing

Part B allowed, 2024
$11,053
Medicare patients
52
Services billed
384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil12$703
Minoxidil15$236

Paid to pharmacies, not to this prescriber.

Other dermatology in Golden

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →